Superworth

Insulet price to book ratio PODD

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
7.3×
10-year median
30.6×
Against its 10-year history
2nd
percentile: 0 is its lowest day, 100 its highest
10-year range
6.4× to 193×
Peer median
3.6×

Insulet's price to book ratio is 7.3× as of Oct 23, 2026.

That is below its ten-year median of 30.6×, lower than on 98% of days in the last ten years.

Over that time it ranged from 6.4× in Oct 2026 to 193× in Jun 2020.

The median for 10 medical instruments and supplies stocks of a similar size is 3.6×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far7.3×6.4×14.7×
202514.7×14.2×17.8×
202416.6×12.8×23.5×
202324.9×16.7×49.6×
202247.8×27.8×50.8×
202136.9×26.3×46.5×
202028.3×23.6×193×
201970.8×21.8×76.2×
201823.2×21.9×60.9×
201754.1×33.4×55.4×
201633.2×25.8×91.7×
201539.0×19.0×39.0×
201432.4×14.9×32.5×
201316.8×12.0×31.6×
201225.9×10.6×27.3×
201110.7×7.6×10.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest Insulet's size, closest first, today.

CompanyPrice to book ratio
PODDInsulet7.3×
GMEDGlobus Medical2.3×
ALGNAlign Technology2.6×
COOCooper Companies1.4×
PENPenumbra8.3×
SOLVSolventum3.0×
MSAMSA Safety5.0×
MMSIMerit Medical Systems3.3×
HAEHaemonetics6.4×
VNTVontier3.9×
BMIBadger Meter6.4×
Peer median3.6×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Insulet

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.